Form 4: Perrigo Director Geoffrey Parker Reports Share Transactions and Power of Attorney

Director Geoffrey Parker reports acquisition and disposal of Perrigo shares, including transactions related to restricted stock units, and a previously established power of attorney.

Summary

• Geoffrey Parker, a director of Perrigo Company plc, filed a Form 4 detailing changes in beneficial ownership.
• On May 15, 2024, Parker acquired 8,764 ordinary shares through the exercise of restricted stock units at a price of $30.22.
• On the same day, Parker disposed of 4,207 ordinary shares to cover tax obligations at a price of $30.22.
• Following these transactions, Parker directly owns 20,262 ordinary shares.
• Parker also holds 9,904 restricted stock units that vest on May 14, 2025.
• The filing also references a power of attorney granted on November 8, 2016, authorizing Todd W. Kingma, Lori Klokkert, David McConnell, and Todd Henke to act on Parker's behalf for SEC filings related to Perrigo securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing reflects routine transactions related to stock-based compensation and tax obligations. There's no indication of significant positive or negative sentiment.

Positives

• The acquisition of shares through restricted stock units indicates a continued investment and alignment with the company's performance.

Negatives

• The disposal of shares to cover tax obligations, while common, slightly reduces Parker's direct holdings in the company.

Risks

• No specific risks are identified in this document.

Industry Context

Form 4 filings are standard practice for company insiders to report transactions in their company's securities, ensuring transparency and compliance with SEC regulations.

Comparison to Industry Standards

• Monitoring insider transactions is a common practice in financial analysis to gauge management's sentiment and confidence in the company's prospects.
• Comparing Parker's transactions with those of other directors or executives in similar pharmaceutical companies could provide further insights into the overall health and outlook of Perrigo relative to its peers.

Stakeholder Impact

• The transactions reported in the Form 4 provide transparency to shareholders regarding insider activity.
• The power of attorney ensures continued compliance with SEC regulations regarding insider trading reporting.

Key Dates